ResMap: A community resource for systematic mapping of therapy-persistent residual cancer cell dependencies across contexts

Xiaoxiao Sun, Savitha Gayathri, Karl Kumbier, Heinz Hammerlindl, Erin Ahern, Lani F. Wu, Steven J. Altschuler · 2026

Read ResMap: A community resource for systematic mapping of therapy-persistent residual cancer cell dependencies across contexts by Xiaoxiao Sun, Savitha Gayathri, Karl Kumbier, Heinz Hammerlindl, Erin Ahern, Lani F. Wu, Steven J. Altschuler (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13262613.txt.

Description

Xiaoxiao Sun and colleagues present a shared resource for studying cancer cells that survive targeted drugs in a 2026 journal article. These persister cells lack stable genetic resistance yet can seed relapse. The resource, called ResMap, offers a standard test setup and a data set so results from different labs can be compared fairly.

The team tested 94 compounds against 57 candidate targets in four lung cancer models, under normal and low oxygen. A first screen found 12 targets with activity across cancer types and oxygen levels, and follow-up work confirmed 9 of them. Some targets worked only in certain settings, including combinations tied to KRAS-driven cancer. Mouse and human cell data added a safety check for ranking targets.

Catalog record

CREATORXiaoxiao Sun, Savitha Gayathri, Karl Kumbier, Heinz Hammerlindl, Erin Ahern, Lani F. Wu, Steven J. Altschuler
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE43985
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13262613

Browse the full library · About the Tower of Babel